Evaluation of 5H‐Thiazolopyrimidin‐5‐ones as Potential GluN2A PET Tracers
We describe here our efforts to develop a PET tracer for imaging GluN2A‐containing NMDA receptors, based on a 5H‐thiazolo[3,2‐α]pyrimidin‐5‐one scaffold. The metabolic stability and overall properties could be optimized satisfactorily, although binding affinities remained a limiting factor for in vi...
Saved in:
Published in | ChemMedChem Vol. 15; no. 24; pp. 2448 - 2461 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Weinheim
Wiley Subscription Services, Inc
01.12.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We describe here our efforts to develop a PET tracer for imaging GluN2A‐containing NMDA receptors, based on a 5H‐thiazolo[3,2‐α]pyrimidin‐5‐one scaffold. The metabolic stability and overall properties could be optimized satisfactorily, although binding affinities remained a limiting factor for in vivo imaging. We nevertheless identified 7‐(((2‐fluoroethyl)(3‐fluorophenyl)amino)‐methyl)‐3‐(2‐(hydroxymethyl)cyclopropyl)‐2‐methyl‐5H‐thiazolo‐[3,2‐α]pyrimidin‐5‐one ([18F]7b) as a radioligand providing good‐quality images in autoradiographic studies, as well as a tritiated derivative, 2‐(7‐(((2‐fluoroethyl)(4‐fluorophenyl)amino)methyl)‐2‐methyl‐5‐oxo‐5H‐thiazolo[3,2‐α]pyrimidin‐3‐yl)cyclopropane‐1‐carbonitrile ([3H2]15b), which was used for the successful development of a radioligand binding assay. These are valuable new tools for the study of GluN2A‐containing NMDA receptors, and for the optimization of allosteric modulators binding to the pharmacophore located at the dimer interface of the GluN1‐GluN2A ligand‐binding domain. |
---|---|
ISSN: | 1860-7179 1860-7187 |
DOI: | 10.1002/cmdc.202000340 |